Fusion Fuel Overview: Highlights of the business, recent developments, details of the QIND transaction, group targets, and NASDAQ compliance. Al Shola Gas Business Update: Overview of Al Shola’s ...
SAN CARLOS, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced ...
Title: Menin Inhibitor Icovamenib Activates Mechanisms That Support Metabolic Health Session: Late-Breaking Poster Session 2871-LB Presenter: Mini Balakrishnan, Ph.D. Date/Time: June 7, 2026, at 12:30 ...
SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present poster presentations at ...
Preliminary data demonstrate FPI-2265 is active in heavily pretreated patients with progressive metastatic castration-resistant prostate cancer (mCRPC), including those who received prior ...
Following the live event, a recording of the presentation, the slides used, and the responses to the question-and-answer session will be made available on the Investor Meet Company platform. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results